DE69105480D1 - Mittel mit erhöhtem Penetrationsvermögen. - Google Patents

Mittel mit erhöhtem Penetrationsvermögen.

Info

Publication number
DE69105480D1
DE69105480D1 DE69105480T DE69105480T DE69105480D1 DE 69105480 D1 DE69105480 D1 DE 69105480D1 DE 69105480 T DE69105480 T DE 69105480T DE 69105480 T DE69105480 T DE 69105480T DE 69105480 D1 DE69105480 D1 DE 69105480D1
Authority
DE
Germany
Prior art keywords
layer
medium
active medicament
solvent
incorporated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69105480T
Other languages
English (en)
Other versions
DE69105480T2 (de
Inventor
Majid Mahjour
Bernadette Mauser
Edwards Eonchao Linn
Zahra Rashidbaigi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32512850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69105480(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ZA91624A external-priority patent/ZA91624B/xx
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE69105480D1 publication Critical patent/DE69105480D1/de
Publication of DE69105480T2 publication Critical patent/DE69105480T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Physical Water Treatments (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Laminated Bodies (AREA)
DE69105480T 1988-03-08 1991-02-19 Mittel mit erhöhtem Penetrationsvermögen. Expired - Fee Related DE69105480T2 (de)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US16532288A 1988-03-08 1988-03-08
NZ236921A NZ236921A (en) 1988-03-08 1991-01-28 Laminate for transmembranal administration of a drug
ZA91624A ZA91624B (en) 1991-01-28 1991-01-28 Delivery device for compositions with enhanced penetration and process for preparing same
AU70061/91A AU634015B2 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
CA002035143A CA2035143A1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
IE30591A IE64308B1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
FI910455A FI910455A (fi) 1988-03-08 1991-01-30 Komposition med foerbaettrad penetration.
NO91910403A NO910403L (no) 1988-03-08 1991-02-01 Fremgangsmaate for fremstilling av farmasoeytisk preparat.
KR1019910001750A KR100191456B1 (ko) 1988-03-08 1991-02-01 침투력이 향상된 조성물
JP3038921A JPH04338325A (ja) 1988-03-08 1991-02-12 増強された浸透性を有する組成物
PT96779A PT96779B (pt) 1988-03-08 1991-02-15 Laminado composito de duas camadas
EP91102354A EP0499662B1 (de) 1988-03-08 1991-02-19 Mittel mit erhöhtem Penetrationsvermögen

Publications (2)

Publication Number Publication Date
DE69105480D1 true DE69105480D1 (de) 1995-01-12
DE69105480T2 DE69105480T2 (de) 1995-04-06

Family

ID=32512850

Family Applications (2)

Application Number Title Priority Date Filing Date
DE89104017T Expired - Fee Related DE68907081T2 (de) 1988-03-08 1989-03-07 Mittel mit erhöhtem Penetrationsvermögen.
DE69105480T Expired - Fee Related DE69105480T2 (de) 1988-03-08 1991-02-19 Mittel mit erhöhtem Penetrationsvermögen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE89104017T Expired - Fee Related DE68907081T2 (de) 1988-03-08 1989-03-07 Mittel mit erhöhtem Penetrationsvermögen.

Country Status (16)

Country Link
EP (2) EP0332147B1 (de)
JP (2) JP2939264B2 (de)
KR (1) KR100191456B1 (de)
AT (2) ATE90571T1 (de)
AU (2) AU611771B2 (de)
CA (1) CA2035143A1 (de)
DE (2) DE68907081T2 (de)
DK (2) DK175621B1 (de)
ES (2) ES2056981T3 (de)
FI (1) FI910455A (de)
GR (1) GR3014988T3 (de)
IE (2) IE62871B1 (de)
NO (1) NO910403L (de)
NZ (2) NZ228094A (de)
PH (1) PH26548A (de)
PT (1) PT96779B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
EP0523150A4 (en) * 1990-04-06 1993-09-29 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
DE4334919A1 (de) * 1993-10-13 1995-04-20 Liedtke Pharmed Gmbh Grenzwertig wirksame Arzneiformen mit Betablockern
WO1996012495A1 (fr) * 1994-10-24 1996-05-02 Nikken Chemicals Co., Ltd Preparation administrable par voie percutanee
DE19533089C1 (de) * 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
US6916486B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US6998138B2 (en) 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6916487B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US6646379B1 (en) 1998-12-25 2003-11-11 Matsushita Electric Industrial Co., Ltd. Metal vapor discharge lamp having cermet lead-in with improved luminous efficiency and flux rise time
EP1137407B1 (de) * 1998-12-11 2004-02-18 Bakulesh Mafatlal Khamar Betablocker und carbopol enthaltende ophtalmische zusammensetzung
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
FR2870125B1 (fr) * 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
RS52671B (en) 2005-10-12 2013-06-28 Unimed Pharmaceuticals Llc IMPROVED TESTOSTERON GEL AND USE PROCEDURE
JP5052558B2 (ja) * 2009-04-03 2012-10-17 ロート製薬株式会社 ゲル軟膏

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107589B (en) * 1981-10-23 1985-04-11 Oreal Anhydrous composition containing anthralin or a derivative for use in the treatment of skin diseases
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
DE3685895T2 (de) * 1985-02-25 1992-12-24 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
US4816456A (en) * 1986-10-01 1989-03-28 Summers William K Administration of monoamine acridines in cholinergic neuronal deficit states
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration

Also Published As

Publication number Publication date
ATE114481T1 (de) 1994-12-15
AU3025889A (en) 1989-09-14
DE68907081T2 (de) 1993-10-21
ES2064780T3 (es) 1995-02-01
AU634015B2 (en) 1993-02-11
NO910403L (no) 1992-08-03
NZ228094A (en) 1991-09-25
DK109689D0 (da) 1989-03-07
DE69105480T2 (de) 1995-04-06
IE910305A1 (en) 1992-07-29
JPH01272519A (ja) 1989-10-31
CA2035143A1 (en) 1992-07-30
JP2939264B2 (ja) 1999-08-25
PH26548A (en) 1992-08-19
AU7006191A (en) 1992-08-20
DK175621B1 (da) 2004-12-27
PT96779B (pt) 1998-09-30
EP0332147A3 (en) 1990-09-19
IE64308B1 (en) 1995-07-26
FI910455A0 (fi) 1991-01-30
PT96779A (pt) 1992-08-31
JPH04338325A (ja) 1992-11-25
AU611771B2 (en) 1991-06-20
GR3014988T3 (en) 1995-05-31
DK109689A (da) 1989-09-09
NZ236921A (en) 1993-08-26
DE68907081D1 (de) 1993-07-22
EP0499662B1 (de) 1994-11-30
EP0499662A1 (de) 1992-08-26
EP0332147A2 (de) 1989-09-13
DK0499662T3 (da) 1995-05-15
EP0332147B1 (de) 1993-06-16
IE62871B1 (en) 1995-03-08
ES2056981T3 (es) 1994-10-16
NO910403D0 (no) 1991-02-01
FI910455A (fi) 1992-07-31
KR920016085A (ko) 1992-09-24
KR100191456B1 (ko) 1999-06-15
ATE90571T1 (de) 1993-07-15
IE890390L (en) 1989-09-08

Similar Documents

Publication Publication Date Title
DE69105480D1 (de) Mittel mit erhöhtem Penetrationsvermögen.
KR900007595A (ko) 개선된 라미네이트 복합체 및 그 제조 방법
CA2075296A1 (en) Spatially modified elastic laminates
DE68921473D1 (de) Geschichtete zusammensetzung für die transdermale verabreichung von fentanyl.
DE3782770D1 (de) Mehrschichtfilm mit guter haftung zwischen den schichten.
NO20000844L (no) Elastiske laminater, samt fremgangsmÕter ved fremstilling derav
AU1948095A (en) Timber structural component with timber layers
DE3677131D1 (de) Laminate und aus diesen hergestellte formen.
DE3853868D1 (de) Wärmehärtende Harzzusammensetzung und Prepreg und laminierter Schichtstoff, die diese verwenden.
EP0264454A4 (de) Verfahren zum ausgleichen der wellungen und verbessern der formbeständigkeit von mit flexiblen metallfolien beschichteten blechen.
DE68925054D1 (de) Verschweisstes Keramik-Metall-Verbundsubstrat, damit aufgebaute Schaltkarte und Verfahren zur Herstellung derselben
ZA984844B (en) Methods for forming extensible laminate structures
BR8904152A (pt) Composicao,composicao curavel,verniz de laminacao,substrato,laminado e composicao de agente de cura
EP1106221A3 (de) Holzschiene für ein Fahrgeschäft sowie Verfahren zur Herstellung und zum Montieren einer solchen Holzschiene
DE68917417D1 (de) Feine Bereiche aufweisende Verbundfolien aus Polyimid-Mischungen.
CA2120458A1 (en) Wood Flooring System
ATE54875T1 (de) Haertbare gummizusammensetzung.
IE842355L (en) Invalid chair based on composite materials.
DK609787A (da) Let konstruktionselement
JPS6487618A (en) Hardening agent composition, laminating vanish and laminated board
IT8722032A0 (it) Composizioni farmaceutiche laminate transdermali ad effetto prolungato e procedimento per la loro preparazione.
NO911279D0 (no) Laminat, samt fremgangsmaate for fremstilling av samme.
DE3670789D1 (de) Selbstdichtende laminate und reifen mit solchem laminat.
KR840003045A (ko) 페놀 코팅 방수합판의 제조방법
DE3860778D1 (de) Flammhemmende harzzusammensetzung und damit hergestelltes laminat.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8339 Ceased/non-payment of the annual fee